Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2012-09-06 21:03:02 UTC
Update Date2022-09-22 18:34:22 UTC
HMDB IDHMDB0028933
Secondary Accession Numbers
  • HMDB28933
Metabolite Identification
Common NameLeucylleucine
DescriptionLeucylleucine, also known as LL or H-L-leu-L-leu-OH, belongs to the class of organic compounds known as peptides. Peptides are compounds containing an amide derived from two or more amino carboxylic acid molecules (the same or different) by formation of a covalent bond from the carbonyl carbon of one to the nitrogen atom of another. Leucylleucine has been detected, but not quantified in, a few different foods, such as anatidaes (Anatidae), chickens (Gallus gallus), and domestic pigs (Sus scrofa domestica). This could make leucylleucine a potential biomarker for the consumption of these foods. Leucylleucine is a secondary metabolite. Secondary metabolites are metabolically or physiologically non-essential metabolites that may serve a role as defense or signalling molecules. In some cases they are simply molecules that arise from the incomplete metabolism of other secondary metabolites. Based on a literature review a significant number of articles have been published on Leucylleucine.
Structure
Data?1582753357
Synonyms
ValueSource
H-L-Leu-L-leu-OHChEBI
H-Leu-leu-OHChEBI
L-Leu-L-leuChEBI
LLChEBI
LL DipeptideChEBI
L-L DipeptideHMDB
L-Leucyl-L-leucineHMDB
Leu-leuHMDB
Leucine leucine dipeptideHMDB
Leucine-leucine dipeptideHMDB
Leucylleucine monohydrochloride, (L-leu-L-leu)-isomerHMDB
Leucylleucine, (L-leu-D-leu)-isomerHMDB
Leucylleucine, (D-leu-D-leu)-isomerHMDB
Leucylleucine, (L-leu-L-leu)-isomerHMDB
L-Leucinyl-L-leucineHMDB
Leucinyl-leucineHMDB
Leucyl-leucineHMDB
N-L-Leucinyl-L-leucineHMDB
N-L-Leucyl-L-leucineHMDB
N-LeucinylleucineHMDB
N-LeucylleucineHMDB
LeucylleucineChEBI
Chemical FormulaC12H24N2O3
Average Molecular Weight244.335
Monoisotopic Molecular Weight244.178692641
IUPAC Name(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-methylpentanoic acid
Traditional Nameleucyl-leucine
CAS Registry Number3303-31-9
SMILES
CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(O)=O
InChI Identifier
InChI=1S/C12H24N2O3/c1-7(2)5-9(13)11(15)14-10(12(16)17)6-8(3)4/h7-10H,5-6,13H2,1-4H3,(H,14,15)(H,16,17)/t9-,10-/m0/s1
InChI KeyLCPYQJIKPJDLLB-UWVGGRQHSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as peptides. Peptides are compounds containing an amide derived from two or more amino carboxylic acid molecules (the same or different) by formation of a covalent bond from the carbonyl carbon of one to the nitrogen atom of another.
KingdomOrganic compounds
Super ClassOrganic acids and derivatives
ClassCarboxylic acids and derivatives
Sub ClassAmino acids, peptides, and analogues
Direct ParentPeptides
Alternative Parents
Substituents
  • Alpha peptide
  • Leucine or derivatives
  • N-acyl-alpha-amino acid
  • N-acyl-alpha amino acid or derivatives
  • Alpha-amino acid or derivatives
  • Branched fatty acid
  • Methyl-branched fatty acid
  • Fatty acyl
  • Fatty acid
  • Amino acid or derivatives
  • Amino acid
  • Carboximidic acid
  • Carboximidic acid derivative
  • Carboxylic acid
  • Monocarboxylic acid or derivatives
  • Organic 1,3-dipolar compound
  • Propargyl-type 1,3-dipolar organic compound
  • Organic oxide
  • Organic oxygen compound
  • Primary aliphatic amine
  • Amine
  • Organic nitrogen compound
  • Hydrocarbon derivative
  • Organonitrogen compound
  • Organooxygen compound
  • Organopnictogen compound
  • Primary amine
  • Carbonyl group
  • Aliphatic acyclic compound
Molecular FrameworkAliphatic acyclic compounds
External Descriptors
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateSolid
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogP-0.87Extrapolated
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
Water Solubility3.27 g/LALOGPS
logP-0.86ALOGPS
logP-0.87ChemAxon
logS-1.9ALOGPS
pKa (Strongest Acidic)4.11ChemAxon
pKa (Strongest Basic)8.43ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count4ChemAxon
Hydrogen Donor Count3ChemAxon
Polar Surface Area92.42 ŲChemAxon
Rotatable Bond Count7ChemAxon
Refractivity65.14 m³·mol⁻¹ChemAxon
Polarizability27.29 ųChemAxon
Number of Rings0ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+168.46830932474
DeepCCS[M-H]-166.1130932474
DeepCCS[M-2H]-198.99630932474
DeepCCS[M+Na]+174.56230932474
AllCCS[M+H]+160.132859911
AllCCS[M+H-H2O]+157.032859911
AllCCS[M+NH4]+162.932859911
AllCCS[M+Na]+163.732859911
AllCCS[M-H]-159.632859911
AllCCS[M+Na-2H]-160.732859911
AllCCS[M+HCOO]-162.132859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
LeucylleucineCC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(O)=O2823.0Standard polar33892256
LeucylleucineCC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(O)=O1815.5Standard non polar33892256
LeucylleucineCC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(O)=O1840.5Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Leucylleucine,1TMS,isomer #1CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)O[Si](C)(C)C1851.8Semi standard non polar33892256
Leucylleucine,1TMS,isomer #2CC(C)C[C@H](NC(=O)[C@H](CC(C)C)N[Si](C)(C)C)C(=O)O1894.8Semi standard non polar33892256
Leucylleucine,1TMS,isomer #3CC(C)C[C@H](N)C(=O)N([C@@H](CC(C)C)C(=O)O)[Si](C)(C)C1848.9Semi standard non polar33892256
Leucylleucine,2TMS,isomer #1CC(C)C[C@H](N[Si](C)(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O[Si](C)(C)C1904.0Semi standard non polar33892256
Leucylleucine,2TMS,isomer #1CC(C)C[C@H](N[Si](C)(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O[Si](C)(C)C1923.7Standard non polar33892256
Leucylleucine,2TMS,isomer #2CC(C)C[C@H](N)C(=O)N([C@@H](CC(C)C)C(=O)O[Si](C)(C)C)[Si](C)(C)C1856.1Semi standard non polar33892256
Leucylleucine,2TMS,isomer #2CC(C)C[C@H](N)C(=O)N([C@@H](CC(C)C)C(=O)O[Si](C)(C)C)[Si](C)(C)C1924.9Standard non polar33892256
Leucylleucine,2TMS,isomer #3CC(C)C[C@H](N[Si](C)(C)C)C(=O)N([C@@H](CC(C)C)C(=O)O)[Si](C)(C)C1892.0Semi standard non polar33892256
Leucylleucine,2TMS,isomer #3CC(C)C[C@H](N[Si](C)(C)C)C(=O)N([C@@H](CC(C)C)C(=O)O)[Si](C)(C)C1945.9Standard non polar33892256
Leucylleucine,2TMS,isomer #4CC(C)C[C@H](NC(=O)[C@H](CC(C)C)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O2021.2Semi standard non polar33892256
Leucylleucine,2TMS,isomer #4CC(C)C[C@H](NC(=O)[C@H](CC(C)C)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O1962.5Standard non polar33892256
Leucylleucine,3TMS,isomer #1CC(C)C[C@H](NC(=O)[C@H](CC(C)C)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O[Si](C)(C)C2039.6Semi standard non polar33892256
Leucylleucine,3TMS,isomer #1CC(C)C[C@H](NC(=O)[C@H](CC(C)C)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O[Si](C)(C)C2073.3Standard non polar33892256
Leucylleucine,3TMS,isomer #2CC(C)C[C@H](N[Si](C)(C)C)C(=O)N([C@@H](CC(C)C)C(=O)O[Si](C)(C)C)[Si](C)(C)C1915.0Semi standard non polar33892256
Leucylleucine,3TMS,isomer #2CC(C)C[C@H](N[Si](C)(C)C)C(=O)N([C@@H](CC(C)C)C(=O)O[Si](C)(C)C)[Si](C)(C)C2025.1Standard non polar33892256
Leucylleucine,3TMS,isomer #3CC(C)C[C@@H](C(=O)O)N(C(=O)[C@H](CC(C)C)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C2031.9Semi standard non polar33892256
Leucylleucine,3TMS,isomer #3CC(C)C[C@@H](C(=O)O)N(C(=O)[C@H](CC(C)C)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C2089.8Standard non polar33892256
Leucylleucine,4TMS,isomer #1CC(C)C[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@H](CC(C)C)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C2089.0Semi standard non polar33892256
Leucylleucine,4TMS,isomer #1CC(C)C[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@H](CC(C)C)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C2185.8Standard non polar33892256
Leucylleucine,1TBDMS,isomer #1CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)O[Si](C)(C)C(C)(C)C2085.3Semi standard non polar33892256
Leucylleucine,1TBDMS,isomer #2CC(C)C[C@H](NC(=O)[C@H](CC(C)C)N[Si](C)(C)C(C)(C)C)C(=O)O2116.9Semi standard non polar33892256
Leucylleucine,1TBDMS,isomer #3CC(C)C[C@H](N)C(=O)N([C@@H](CC(C)C)C(=O)O)[Si](C)(C)C(C)(C)C2068.5Semi standard non polar33892256
Leucylleucine,2TBDMS,isomer #1CC(C)C[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O[Si](C)(C)C(C)(C)C2352.5Semi standard non polar33892256
Leucylleucine,2TBDMS,isomer #1CC(C)C[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O[Si](C)(C)C(C)(C)C2298.9Standard non polar33892256
Leucylleucine,2TBDMS,isomer #2CC(C)C[C@H](N)C(=O)N([C@@H](CC(C)C)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2309.1Semi standard non polar33892256
Leucylleucine,2TBDMS,isomer #2CC(C)C[C@H](N)C(=O)N([C@@H](CC(C)C)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2301.8Standard non polar33892256
Leucylleucine,2TBDMS,isomer #3CC(C)C[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N([C@@H](CC(C)C)C(=O)O)[Si](C)(C)C(C)(C)C2365.7Semi standard non polar33892256
Leucylleucine,2TBDMS,isomer #3CC(C)C[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N([C@@H](CC(C)C)C(=O)O)[Si](C)(C)C(C)(C)C2308.2Standard non polar33892256
Leucylleucine,2TBDMS,isomer #4CC(C)C[C@H](NC(=O)[C@H](CC(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O2471.6Semi standard non polar33892256
Leucylleucine,2TBDMS,isomer #4CC(C)C[C@H](NC(=O)[C@H](CC(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O2340.3Standard non polar33892256
Leucylleucine,3TBDMS,isomer #1CC(C)C[C@H](NC(=O)[C@H](CC(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C2712.1Semi standard non polar33892256
Leucylleucine,3TBDMS,isomer #1CC(C)C[C@H](NC(=O)[C@H](CC(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C2605.3Standard non polar33892256
Leucylleucine,3TBDMS,isomer #2CC(C)C[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N([C@@H](CC(C)C)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2585.2Semi standard non polar33892256
Leucylleucine,3TBDMS,isomer #2CC(C)C[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N([C@@H](CC(C)C)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2565.1Standard non polar33892256
Leucylleucine,3TBDMS,isomer #3CC(C)C[C@@H](C(=O)O)N(C(=O)[C@H](CC(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2714.0Semi standard non polar33892256
Leucylleucine,3TBDMS,isomer #3CC(C)C[C@@H](C(=O)O)N(C(=O)[C@H](CC(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2608.2Standard non polar33892256
Leucylleucine,4TBDMS,isomer #1CC(C)C[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@H](CC(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2968.6Semi standard non polar33892256
Leucylleucine,4TBDMS,isomer #1CC(C)C[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@H](CC(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2878.8Standard non polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Experimental GC-MSGC-MS Spectrum - Leucylleucine EI-B (Non-derivatized)splash10-000b-7090000000-09a4ae51d224ef58134e2019-05-16HMDB team, MONA, MassBankView Spectrum
Experimental GC-MSGC-MS Spectrum - Leucylleucine EI-B (Non-derivatized)splash10-000b-7090000000-09a4ae51d224ef58134e2019-05-16HMDB team, MONA, MassBankView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Leucylleucine GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Experimental LC-MS/MSLC-MS/MS Spectrum - Leucylleucine 30V, Positive-QTOFsplash10-000l-9000000000-f77b348bf5ada2258de72021-09-20HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Leucylleucine 40V, Positive-QTOFsplash10-0006-9000000000-d3fc86dcb525479679a52021-09-20HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Leucylleucine 20V, Positive-QTOFsplash10-000i-9000000000-53c5211338e8ad3353032021-09-20HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Leucylleucine 10V, Positive-QTOFsplash10-000i-9010000000-6fa0b46863aac2c409142021-09-20HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Leucylleucine 10V, Positive-QTOFsplash10-000i-9020000000-1bfd07dd678796e422092021-09-20HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Leucylleucine 30V, Positive-QTOFsplash10-000i-9000000000-5cd53fff1fe6e8e9150f2021-09-20HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Leucylleucine 10V, Positive-QTOFsplash10-000i-9020000000-26984d95015e1667ed902021-09-20HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Leucylleucine 0V, Positive-QTOFsplash10-0002-0090000000-eb25da76cb171db2edc52021-09-20HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Leucylleucine 30V, Positive-QTOFsplash10-000l-9000000000-84ed4443430bf1179c952021-09-20HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Leucylleucine 0V, Positive-QTOFsplash10-0002-0090000000-3a9b27807923baba1ad62021-09-20HMDB team, MONAView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Leucylleucine 10V, Negative-QTOFsplash10-000x-0590000000-76619d9b95ec5a0f69ef2021-09-22Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Leucylleucine 20V, Negative-QTOFsplash10-001i-2900000000-18a16687b283efd8677c2021-09-22Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Leucylleucine 40V, Negative-QTOFsplash10-000x-9300000000-8e65033a5281e403089e2021-09-22Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Leucylleucine 10V, Positive-QTOFsplash10-0002-3290000000-56f4948ff3444188ed4d2021-09-22Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Leucylleucine 20V, Positive-QTOFsplash10-000i-9200000000-06a4cc17d15abe0335d82021-09-22Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Leucylleucine 40V, Positive-QTOFsplash10-00ko-9000000000-7a1d1b7f6830603681612021-09-22Wishart LabView Spectrum

NMR Spectra

Spectrum TypeDescriptionDeposition DateSourceView
Predicted 1D NMR1H NMR Spectrum (1D, 100 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 100 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 1000 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 1000 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 200 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 200 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 300 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 300 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 400 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 400 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 500 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 500 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 600 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 600 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 700 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 700 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 800 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 800 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 900 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 900 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
  • Feces
  • Saliva
  • Urine
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Both
Normal
details
SalivaDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Male
Normal
details
SalivaDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Male
Normal
details
SalivaDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Male
Normal
details
SalivaDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Male
Normal
details
SalivaDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Male
Normal
details
SalivaDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Male
Normal
details
SalivaDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Male
Normal
details
SalivaDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Male
Normal
details
SalivaDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Male
Normal
details
SalivaDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Male
Normal
details
Abnormal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodExpected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedCancer patients undergoing total body irradiation details
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Both
Colorectal cancer
details
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Both
Colorectal cancer
details
UrineDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedCancer patients undergoing total body irradiation details
Associated Disorders and Diseases
Disease References
Colorectal cancer
  1. Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016. [PubMed:27015276 ]
  2. Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
Associated OMIM IDs
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDFDB111960
KNApSAcK IDC00038887
Chemspider ID69263
KEGG Compound IDC11332
BioCyc IDL-LEUCYL-L-LEUCINE
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound94244
PDB IDNot Available
ChEBI ID73531
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Nath M, Pokharia S, Eng G, Song X, Kumar A: New triorganotin (IV) derivatives of dipeptides as models for metal-protein interactions: synthesis, structural characterization and biological studies. Spectrochim Acta A Mol Biomol Spectrosc. 2006 Jan;63(1):66-75. Epub 2005 Jun 9. [PubMed:15950528 ]
  2. Lacha J, Hubacek JA, Potmesil P, Viklicky O, Malek I, Vitko S: TGF-beta I gene polymorphism in heart transplant recipients--effect on renal function. Ann Transplant. 2001;6(1):39-43. [PubMed:11803605 ]
  3. Takahashi N, Sato T: Preferential utilization of dipeptides by Porphyromonas gingivalis. J Dent Res. 2001 May;80(5):1425-9. [PubMed:11437213 ]
  4. Zhao HL, Zang J, Li ZY, Zhang X, Jiang S, Liu J, Wei X, He Y: [Generation of human monoclonal antibodies against hemorrhagic fever with renal sydrome (HFRS) virus]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 1997 Mar;11(1):66-8. [PubMed:15619910 ]
  5. Chakravarty MM, Felsky D, Tampakeras M, Lerch JP, Mulsant BH, Kennedy JL, Voineskos AN: DISC1 and Striatal Volume: A Potential Risk Phenotype For mental Illness. Front Psychiatry. 2012 Jun 19;3:57. doi: 10.3389/fpsyt.2012.00057. eCollection 2012. [PubMed:22723785 ]
  6. Makarevic J, Jokic M, Frkanec L, Caplar V, Sijakovic Vujicic N, Zinic M: Oxalyl retro-peptide gelators. Synthesis, gelation properties and stereochemical effects. Beilstein J Org Chem. 2010 Oct 4;6:945-59. doi: 10.3762/bjoc.6.106. [PubMed:21085503 ]
  7. Podstawka E, Ozaki Y, Proniewicz LM: Part I: surface-enhanced Raman spectroscopy investigation of amino acids and their homodipeptides adsorbed on colloidal silver. Appl Spectrosc. 2004 May;58(5):570-80. [PubMed:15165334 ]
  8. Hebert EM, Mamone G, Picariello G, Raya RR, Savoy G, Ferranti P, Addeo F: Characterization of the pattern of alphas1- and beta-casein breakdown and release of a bioactive peptide by a cell envelope proteinase from Lactobacillus delbrueckii subsp. lactis CRL 581. Appl Environ Microbiol. 2008 Jun;74(12):3682-9. doi: 10.1128/AEM.00247-08. Epub 2008 Apr 18. [PubMed:18424544 ]
  9. Banan A, Farhadi A, Fields JZ, Mutlu E, Zhang L, Keshavarzian A: Evidence that nuclear factor-kappa B activation is critical in oxidant-induced disruption of the microtubule cytoskeleton and barrier integrity and that its inactivation is essential in epidermal growth factor-mediated protection of the monolayers of intestinal epithelia. J Pharmacol Exp Ther. 2003 Jul;306(1):13-28. [PubMed:12815011 ]
  10. Graf J, Hodgson R, van Daal A: Single nucleotide polymorphisms in the MATP gene are associated with normal human pigmentation variation. Hum Mutat. 2005 Mar;25(3):278-84. [PubMed:15714523 ]
  11. Uchimoto T, Nohara H, Kamehara R, Iwamura M, Watanabe N, Kobayashi Y: Mechanism of apoptosis induced by a lysosomotropic agent, L-Leucyl-L-Leucine methyl ester. Apoptosis. 1999 Oct;4(5):357-62. [PubMed:14634338 ]